These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12399892)

  • 1. [Initial results of multicenter, randomized, controlled therapy studies of ANCA-associated vasculitis].
    De Groot K
    Z Rheumatol; 2002 Oct; 61(5):607-9. PubMed ID: 12399892
    [No Abstract]   [Full Text] [Related]  

  • 2. 4. Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis: from molecular analysis to bedside.
    Yoshida M
    Intern Med; 2002 Jan; 41(1):47-9. PubMed ID: 11838592
    [No Abstract]   [Full Text] [Related]  

  • 3. [Initial results of multicenter, randomized, controlled therapy studies for ANCA-associated vasculitis].
    de Groot K
    Z Rheumatol; 2003 Apr; 62(2):116-7. PubMed ID: 12820617
    [No Abstract]   [Full Text] [Related]  

  • 4. [What's new in systemic vasculitis?].
    Müller A; Csernok E
    Z Rheumatol; 2002 Oct; 61(5):610-2. PubMed ID: 12399893
    [No Abstract]   [Full Text] [Related]  

  • 5. [ANCA vasculitis].
    Bernis C
    Nefrologia; 2003; 23(2):103-6. PubMed ID: 12778872
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-TNF alpha agents in vasculitis].
    Solans Laqué R; Bosch Gil JA
    Med Clin (Barc); 2008 Feb; 130(3):93-4. PubMed ID: 18261379
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary vasculitis.
    Burns A
    Br J Hosp Med; 1997 Oct 15-Nov 4; 58(8):389-92. PubMed ID: 9509040
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic vasculitis: still a challenging disease.
    Buhaescu I; Covic A; Levy J
    Am J Kidney Dis; 2005 Aug; 46(2):173-85. PubMed ID: 16112036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?
    Flossmann O; de Groot K
    Nat Clin Pract Nephrol; 2007 May; 3(5):236-7. PubMed ID: 17457358
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypertrophic pachymeningitis, glomerulonephritis and P-ANCA associated small vessel vasculitis].
    Mazzocchi O; Risso JA; Viozzi F; Apa NP; Peralba MC; Nadal MA; De Rosa GE
    Medicina (B Aires); 2007; 67(2):151-5. PubMed ID: 17593600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational research in autoimmunity: aims of therapy in vasculitis.
    Watts R; Harper L; Jayne D; Levy J; Pusey C; Savage C; Scott DG; Williams J
    Rheumatology (Oxford); 2005 May; 44(5):573-6. PubMed ID: 15797978
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
    Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
    Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.
    Gao Y; Chen M; Ye H; Yu F; Guo XH; Zhao MH
    Rheumatology (Oxford); 2008 Oct; 47(10):1515-20. PubMed ID: 18676500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
    Lapraik C; Watts R; Bacon P; Carruthers D; Chakravarty K; D'Cruz D; Guillevin L; Harper L; Jayne D; Luqmani R; Mooney J; Scott D;
    Rheumatology (Oxford); 2007 Oct; 46(10):1615-6. PubMed ID: 17804455
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
    Jayne DR; Rasmussen N
    Mayo Clin Proc; 1997 Aug; 72(8):737-47. PubMed ID: 9276602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunology in clinical practice IX. Systemic vasculitis].
    Kallenberg CG; Tervaert JW
    Ned Tijdschr Geneeskd; 1998 Jan; 142(3):118-23. PubMed ID: 9557008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Sanders JS; Slot MC; Stegeman CA
    N Engl J Med; 2003 Nov; 349(21):2072-3; author reply 2072-3. PubMed ID: 14627795
    [No Abstract]   [Full Text] [Related]  

  • 18. [Are anti-TNFAb indicated in systemic necrotizing vasculitides?].
    Guillevin L
    Rev Med Interne; 2005 Oct; 26(10):769-70. PubMed ID: 16039017
    [No Abstract]   [Full Text] [Related]  

  • 19. Inflammation: Rituximab in ANCA vasculitis and lupus: bittersweet results.
    Bosch X
    Nat Rev Nephrol; 2010 Mar; 6(3):137-9. PubMed ID: 20186231
    [No Abstract]   [Full Text] [Related]  

  • 20. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):207-19. PubMed ID: 8499059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.